Noveris Health Sciences is trading at CA$0.16, up +6.67% on August 31, 2026, with no new company announcement found during the morning session.
- The latest identifiable catalyst remains the proposed CA$500,000 convertible-debenture financing, announced August 20 and expected to close around August 28.
- The financing previously raised dilution concerns.
- Broader markets were modestly lower, so market direction does not clearly explain the advance.